Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jul;42(7):715-719.
doi: 10.1007/s40273-024-01364-0. Epub 2024 Mar 18.

Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling

Isaac Corro Ramos  1 , Talitha Feenstra  2   3 , Salah Ghabri  4 , Maiwenn Al  5
Affiliations
Editorial

Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling

Isaac Corro Ramos et al. Pharmacoeconomics. 2024 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Isaac Corro Ramos, Talitha Feenstra, Salah Ghabri and Maiwenn Al have no conflicts of interest that are directly relevant to the content of this editorial.

References

    1. Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Value Health. 2012;15(6):843–850. doi: 10.1016/j.jval.2012.04.012. - DOI - PubMed
    1. Ghabri S, Stevenson M, Möller J, Caro JJ. Trusting the results of model-based economic analyses: is there a pragmatic validation solution? Pharmacoeconomics. 2019;37(1):1–6. doi: 10.1007/s40273-018-0711-9. - DOI - PubMed
    1. Vemer P, van Voom GAK, Ramos IC, Krabbe PFM, Al MJ, Feenstra TL. Improving model validation in health technology assessment: comments on guidelines of the ISPOR-SMDM modeling good research practices task force. Value Health J Int Soc Pharmacoecon Outcomes Res. 2013;16(6):1106–1107. doi: 10.1016/j.jval.2013.06.015. - DOI - PubMed
    1. Caro JJ, Möller J. Decision-analytic models: current methodological challenges. Pharmacoeconomics. 2014;32(10):943–950. doi: 10.1007/s40273-014-0183-5. - DOI - PubMed
    1. Karnon J. Model validation: has it’s time come? Pharmacoeconomics. 2016;34(9):829–831. doi: 10.1007/s40273-016-0415-y. - DOI - PubMed

Publication types

LinkOut - more resources